Zhongheng Group: The company's drugs have not entered the scope of centralized procurement in Guangdong, which has a certain impact on the company's operations.

Post date May 17, 2022 — 09:28 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Zhongheng Group: The company's pharmaceutical research and development direction is mainly concentrated in the field of traditional Chinese medicine research and development, mainly in the fields of cardiovascular and cerebrovascular, classic traditional Chinese medicine and other fields

May 17, 2022 — 09:30

Zhongheng Group: The company will adjust its sales strategy in a timely manner and drive the volume of retail products from multiple dimensions.

May 17, 2022 — 09:30

Zhongheng Group: The company's investment in the construction of a pharmaceutical intelligent manufacturing valley is based on sufficient research and demonstration, and investment decisions are made prudently and scientifically.

May 17, 2022 — 09:27

Zhongheng Group: Standardized corporate governance, all production and operation conditions are normal.

May 17, 2022 — 09:26

Zhongheng Group: Researches related to the upgrading of Xueshuantong (lyophilized) technology for injection have been completed.

May 17, 2022 — 09:25

Zhongheng Group: The company has formed an industrial layout of Chinese patent medicines, APIs, chemical medicines, generic medicines, biological medicines, pharmaceutical distribution, and daily chemical supplies

May 17, 2022 — 09:25

Zhongheng Group: The company's epidemic prevention products are normally sold externally. At present, the company's masks and other protective products account for a small proportion of the company's consolidated revenue and profits.

May 17, 2022 — 09:25

Zhongheng Group: Researches related to the upgrading of Xueshuantong (lyophilized) technology for injection have been completed.

May 17, 2022 — 09:25

Zhongheng Group: The company's epidemic prevention products are normally sold externally. At present, the company's masks and other protective products account for a small proportion of the company's consolidated revenue and profits.

May 17, 2022 — 09:25

Home » News » Zhongheng Group: The company's drugs have not entered the scope of centralized procurement in Guangdong, which has a certain impact on the company's operations.